Percutaneous closure of patent foramen ovale and atrial septal defect in adults: The impact of clinical variables and hospital procedure volume on in-hospital adverse events

American Heart Journal

Volumn 157, Issue 5, 2009, Pages 867-874

  Opotowsky, Alexander R ^a   Landzberg, Michael J ^b   Kimmel, Stephen E ^a   Webb, Gary D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ACUTE POSTHEMORRHAGIC ANEMIA; ACUTE RESPIRATORY FAILURE; ADULT; AGE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURES; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE EXACERBATION; EMERGENCY CARE; FEMALE; GENDER; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEMATOMA; HOSPITAL ADMISSION; HOSPITAL CHARGE; HUMAN; IATROGENIC DISEASE; INFLAMMATION; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRACARDIAC ECHOCARDIOGRAPHY; LENGTH OF STAY; LUNG COLLAPSE; LUNG COMPLICATION; LUNG EDEMA; LUNG EMBOLISM; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIAL EFFUSION; PERICARDITIS; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS INFECTION; SEROMA; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

CARDIAC SURGICAL PROCEDURES; FEMALE; FORAMEN OVALE, PATENT; HEART SEPTAL DEFECTS, ATRIAL; HOSPITALS, SPECIAL; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RISK FACTORS; UNITED STATES;

EID: 64349119764     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.02.019     Document Type: Article

References (43)

1. King T.D., Thompson S.L., Steiner C., et al. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235 (1976) 2506-2509
2. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J 112 (1986) 141-145
3. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
4. Overell J.R., Bone I., and Lees K.R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55 (2000) 1172-1179
5. Wu L.A., Malouf J.F., Dearani J.A., et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 164 (2004) 950-956
6. Kizer J.R., and Devereux R.B. Clinical practice. patent foramen ovale in young adults with unexplained stroke. N Engl J Med 353 (2005) 2361-2372
7. Silva M.T., Rodrigues R., Tress J., et al. Patent foramen ovale in a cohort of young patients with cryptogenic ischemic stroke. Arq Neuropsiquiatr 63 (2005) 427-429
8. Meier B., and Lock J.E. Contemporary management of patent foramen ovale. Circulation 107 (2003) 5-9
9. Landzberg M.J., and Khairy P. Indications for the closure of patent foramen ovale. Heart 90 (2004) 219-224
10. Ilkhanoff L., Naidu S.S., Rohatgi S., et al. Transcatheter device closure of interatrial septal defects in patients with hypoxia. J Interv Cardiol 18 (2005) 227-232
11. Morandi E., Anzola G.P., Casilli F., et al. Migraine: traditional or "innovative" treatment? A preliminary case-control study. Pediatr Cardiol 26 (2005) 231-233
12. Schwerzmann M., Wiher S., Nedeltchev K., et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62 (2004) 1399-1401
13. Meissner I., Khandheria B.K., Heit J.A., et al. Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47 (2006) 440-445
14. Petty G.W., Khandheria B.K., Meissner I., et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 81 (2006) 602-608
15. Di Tullio M.R., Sacco R.L., Sciacca R.R., et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49 (2007) 797-802
16. Opotowsky A.R., Landzberg M.J., Kimmel S.E., et al. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA 299 (2008) 521-522
17. Khairy P., O'Donnell C.P., and Landzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139 (2003) 753-760
18. Herrmann H.C., Silvestry F.E., Glaser R., et al. Percutaneous patent foramen ovale and atrial septal defect closure in adults: results and device comparison in 100 consecutive implants at a single center. Catheter Cardiovasc Interv 64 (2005) 197-203
19. Bruch L., Parsi A., Grad M.O., et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 105 (2002) 2845-2848
20. Braun M., Gliech V., Boscheri A., et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25 (2004) 424-430
21. Aslam F., Iliadis A.E., and Blankenship J.C. Percutaneous closure of patent foramen ovale: success and outcomes of a low-volume procedure at a rural medical center. J Invasive Cardiol 19 (2007) 20-24
22. Alameddine F., and Block P.C. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc Interv 62 (2004) 512-516
23. Martin F., Sanchez P.L., Doherty E., et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 106 (2002) 1121-1126
24. Krumsdorf U., Ostermayer S., Billinger K., et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 43 (2004) 302-309
25. Schuchlenz H.W., Mannweiler S., and Martin D. Marked foreign body reaction and thrombus formation after transcatheter closure of a patent foramen ovale. J Thorac Cardiovasc Surg 130 (2005) 591-592
26. Clarke A.C., Hirsch K.J., Kells C.M., et al. Thrombus formation on an atrial septal defect closure device. Can J Cardiol 21 (2005) 68-70
27. Lange S.A., Schoen S.P., Braun M.U., et al. Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interv Cardiol 19 (2006) 166-169
28. Trivedi A.N., Sequist T.D., and Ayanian J.Z. Impact of hospital volume on racial disparities in cardiovascular procedure mortality. J Am Coll Cardiol 47 (2006) 417-424
29. Sung V.W., Rogers M.L., Myers D.L., et al. Impact of hospital and surgeon volumes on outcomes following pelvic reconstructive surgery in the United States. Am J Obstet Gynecol 195 (2006) 1778-1783
30. Hannan E.L., Wu C., Walford G., et al. Volume-Outcome relationships for percutaneous coronary interventions in the stent era. Circulation 112 (2005) 1171-1179
31. Snider RL, Laskey WK. Quality management and volume-related outcomes in the cardiac catheterization laboratory. Cardiol Clin. 2006;24:287, 97, vii.
32. Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow up. Heart 91 (2005) 444-448
33. Karamlou T., Diggs B.S., Ungerleider R.M., et al. The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization?. Ann Thorac Surg 86 (2008) 1584-1591
34. Santry H.P., Gillen D.L., and Lauderdale D.S. Trends in bariatric surgical procedures. JAMA 294 (2005) 1909-1917
35. Dimick JB, Pronovost PJ, Cowan Jr JA, et al. Variation in postoperative complication rates after high-risk surgery in the united states. Surgery. 2003;134:534, 40 [discussion 540-1].
36. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 36 (1998) 8-27
37. Introduction to the HCUP Nationwide Inpatient Sample (NIS), 2005; June, 2007. Available at. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.pdf Last accessed December 8, 2008
38. King III S.B., Aversano T., et al. ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 116 (2007) 98-124
39. Houchens R.L., and Elixhauser A. Using the HCUP Nationwide Inpatient Sample to estimate trends (updated for 1988-2004) HCUP Methods Series Report #2006-05 Online; August 18, 2006. Available at. http://www.hcup-us.ahrq.gov/reports/methods.jsp Last accessed December 8, 2008
40. Cole S.R. Analysis of complex survey data using SAS. Comput Methods Programs Biomed 64 (2001) 65-69
41. Epstein A.M. Volume and outcome-it is time to move ahead. N Engl J Med 346 (2002) 1161-1164
42. Miller M.R., Elixhauser A., Zhan C., et al. Patient safety indicators: using administrative data to identify potential patient safety concerns. Health Serv Res 36 6 Pt 2 (2001) 110-132
43. Lawthers A.G., McCarthy E.P., Davis R.B., et al. Identification of in-hospital complications from claims data. Is it valid?. Med Care 38 (2000) 785-795